Every prescription is a clinical trial
Systematic review combined with a double blind evaluation has not supported it as an evidence based treatment, 3 yet individual patients are reported as deriving notable benefit, which, in this typical case was 18 months' pain relief after two treatments. 4 As it remains, however, a useful and...
Saved in:
Published in | BMJ Vol. 329; no. 7478; p. 1346 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
England
British Medical Association
04.12.2004
BMJ Publishing Group LTD BMJ Publishing Group Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Systematic review combined with a double blind evaluation has not supported it as an evidence based treatment, 3 yet individual patients are reported as deriving notable benefit, which, in this typical case was 18 months' pain relief after two treatments. 4 As it remains, however, a useful and valued component of the planned staged approach to the management of chronic regional pain syndrome type 1, many pain clinicians will continue to include it or an equivalent intervention in their armamentarium. 5 An additional problem that regularly occurs is the removal from the market of valuable drugs (although often for limited indications) which are effective in, and appropriate for, many individual patients. |
---|---|
Bibliography: | SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1 ObjectType-Commentary-2 Competing interests: None declared. |
ISSN: | 0959-8138 1468-5833 1756-1833 |
DOI: | 10.1136/bmj.329.7478.1346 |